References
- Gleich GJ., Flavahan NA., Fujisawa T, Vanhouette PM. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 1988; 81: 776–81
- Dahl R. Eosinophils and eosinophil products. Allergic and vasomotor rhinitis: Pathophysiological aspects, N Mygind, U Pipkorn. Munksgaard, Copenhagen 1987; 136–9
- Filley W V, Holley K E, Kephart G M, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with asthma. Lancet 1982; ii: 11–6
- Wegner C D, Gundel R H, Reilly P, Haynes N L, Letts G, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247: 456–9
- Klementsson H, Andersson M, Baumgarten C R, Venge P, Pipkorn U. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy 1990; 20: 539–47
- Andersson M, Andersson P, Venge P, Pipkorn U. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment. Allergy 1989; 44: 342–8
- Naclerio R M, Meier H L, Kagey-Sobotka A. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 128: 597–602
- Pipkorn U, Karlsson G, Enerback L. A brush method to harvest cells from the nasal mucosa for microscopic and biochemical analysis. J Immunol Methods 1988; 112: 37–42
- Borum P. Nasal methacholine challenge. J Allergy Clin Immunol 1979; 63: 253–7
- Venge P, Roxin L E, Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol 1977; 37: 331–5
- Gronborg H, Borum P, Mygind N. Histamine and methacholine do not increase nasal reactivity. Clin Allergy 1986; 16: 597–602
- Raphael G D, Druce H M, Baraniuk J N, Kaliner MA. Pathophysiology of rhinitis. 1. Assessment of the sources of protein in methacholine-induced nasal secretions. Am Rev Respir Dis 1988; 138: 413–20
- Brofeldt S, Mygind N, S0rensen CH, Readman A S, Marriott C. Biochemical analysis of nasal secretions induced by methacholine. histamine and allergen provocations. Am Rev Respir Dis 1986; 133: 1138–42
- Linder A, Venge P, Deuschl H. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis. Allergy 1987; 42: 583–90
- Bisgaard H, Gronborg H, Mygind N, Dahl R, Lindqvist N, Venge P. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: Effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990; 85: 891–5
- Klementsson H, Andersson M, Pipkorn U. Allergen-induced increase in non-specific nasal reactivity is blocked by antihistamines; without a clear-cut relationship to eosinophil influx. J Allergy Clin Immunol 1990; 86: 466–72
- Klementsson H, Lindqvist N, Andersson M, Pipkorn U. Effect of a single dose of a topical glucocorticoid and a cyclo-oxygenase inhibitor on allergen-induced changes in nasal reactivity. Allergy 1990; 45: 604–11
- Andersson M, Andersson P, Pipkorn U. Allergen-induced specific and non-specific nasal reactions; reciprocal relationship and inhibition by topical glucocorticosteroids. Acta Otolaryngol (Stockh) 1989; 107: 270–7